Il mercato degli enzimi, dei kit e dei reagenti per biologia molecolare sarà probabilmente valutato a 15.715,48 milioni di dollari nel 2022 e si prevede che raggiungerà i 41.104,71 milioni di dollari entro il 2028; si prevede che crescerà a un CAGR del 17,8% dal 2022 al 2028.
Gli enzimi biologici svolgono un ruolo di primo piano nell'incoraggiare le reazioni chimiche nei sistemi biologici. Per la preparazione dei campioni di laboratorio si consigliano enzimi di biologia molecolare. Questi reagenti vengono utilizzati anche durante vari processi come la reazione a catena della polimerasi (PCR), il sequenziamento del DNA e l'analisi cellulare. La crescita del mercato è attribuita ad alcuni fattori trainanti chiave, come i consistenti finanziamenti per la genomica, la diminuzione dei costi delle procedure di sequenziamento e la crescente prevalenza di malattie croniche. Tuttavia, la carenza di professionisti qualificati ostacola la crescita del mercato.Il mercato degli enzimi, dei kit e dei reagenti per biologia molecolare sta assistendo a una crescita sostanziale nel contesto della pandemia di COVID-19. La maggior parte delle organizzazioni di ricerca sanitaria, degli operatori di mercato e dei centri accademici sono attivamente impegnati nelle attività di ricerca e sviluppo per sviluppare nuovi vaccini e piattaforme terapeutiche per il nuovo coronavirus che causa COVID-19. Si prevede che questo ampio aumento delle attività di ricerca e sviluppo aumenterà la domanda di kit e reagenti per biologia molecolare, che, a sua volta, guiderà la crescita del mercato degli enzimi, dei kit e dei reagenti per biologia molecolare nei prossimi anni.
Approfondimenti strategici
Regioni redditizie per il mercato degli enzimi, dei kit e dei reagenti per la biologia molecolare
Approfondimenti sul mercato
Un finanziamento sano per la genomica guida la crescita del mercato
Qualche anno fa il sequenziamento del genoma era limitato alle strutture di ricerca. Tuttavia, ora è diventata una delle tecniche comuni nella pratica clinica. Si prevede che nei prossimi anni il settore sanitario genererà dati genomici di oltre 60 milioni di pazienti. La crescente implementazione del sequenziamento genomico nei sistemi sanitari è supportata da ingenti investimenti governativi, per un totale di oltre 4 miliardi di dollari in almeno 14 paesi. Il Regno Unito ha annunciato il più grande progetto sul genoma del mondo nell'ambito di una collaborazione pubblica e privata da 200 milioni di persone tra organizzazioni di beneficenza e aziende farmaceutiche. Il paese ha già sviluppato il più grande database del genoma del mondo attraverso il progetto 100.000 Genomes. Guidato da Innovate UK, una parte di UK Research and Innovation, il progetto è stato avviato per supportare ricercatori e industrie attraverso fondi per combinare dati e prove del mondo reale ottenuti dai servizi sanitari del Regno Unito, nonché per creare nuovi prodotti e servizi per servizi più efficienti e diagnosi precoce delle malattie.
Nel novembre 2018, Stilla Technologies, Francia, ha annunciato il completamento di un round di finanziamento di serie A, raccogliendo fondi per 18,3 milioni di dollari (16 milioni di euro); il round è stato guidato da Illumina Ventures. L'azienda prevede di utilizzare questi fondi per la commercializzazione del suo sistema PCR digitale Naica e lo sviluppo di applicazioni cliniche. Inoltre, nel giugno 2020, Base Genomics, una società di epigenetica con sede a Oxford, in Inghilterra, ha chiuso un round di finanziamento iniziale di 11 milioni di dollari (9 milioni di sterline). Nell’agosto 2018, Nebula Genomics, una società con sede a Boston, Massachusetts, insieme a 10 importanti società di venture capital, ha raccolto 4,3 milioni di dollari in finanziamenti iniziali. come parte della partnership con Veritas Genetics, una società di sequenziamento del genoma. L’azienda mira a utilizzare questi fondi per creare un mercato affidabile, sicuro e decentralizzato per i dati genomici. Nel marzo 2018, SynbiCITE (Regno Unito) ha ricevuto sovvenzioni per un valore di circa 17,6 milioni di dollari (13 milioni di sterline) e investimenti privati per un valore di 318,5 milioni di dollari (234 milioni di sterline). L'azienda è creata per aumentare le applicazioni synbio nel Regno Unito. SynbiCITE ha supportato synbio a livello nazionale per l'aumento delle applicazioni di sintesi genetica.
Nell'aprile 2020, MedGenome, una società di diagnostica genetica, ricerca e dati con sede a Bangalore, in India, ha raccolto 55 milioni di dollari (~ ₹ 419 crore) in un nuovo round di finanziamento, guidato da LeapFrog Investments, una società di investimenti a impatto globale. MedGenome afferma inoltre di aver creato il più grande database di varianti genetiche dell'Asia meridionale nella diagnostica genetica in India e in partenariati di ricerca. Fino ad oggi ha condotto oltre 200.000 test genomici ottenendo campioni da più di 550 ospedali e 6.000 medici in tutta l'India.
Tale finanziamento continuo da parte dei produttori e dei governi nel campo della genomica sta supportando gli enzimi di biologia molecolare, crescita del mercato di kit e reagenti.
Mercato degli enzimi, dei kit e dei reagenti per biologia molecolare, per prodotto: 2022 e 2028
Approfondimenti basati sul prodotto
Basati sul prodotto, sugli enzimi, sui kit e sui reagenti di biologia molecolare il mercato è diviso in enzimi e kit & reagenti. Il mercato, per enzimi, è ulteriormente segmentato in polimerasi, ligasi, trascrittasi inversa, fosfatasi, proteasi e proteinasi, endonucleasi di restrizione e altro. I kit e gli accessori il segmento dei reagenti ha detenuto una quota di mercato maggiore nel 2020 e si stima che lo stesso segmento registrerà un CAGR più elevato durante il periodo di previsione.
Approfondimenti basati sull'applicazione
Gli enzimi e i kit di biologia molecolare e il mercato dei reagenti, in base all'applicazione, è segmentato in epigenetica, sequenziamento, biologia sintetica, reazione a catena della polimerasi e altro. Nel 2020, il segmento del sequenziamento deteneva la quota di mercato maggiore. Tuttavia, si stima che il segmento della reazione a catena della polimerasi registrerà il CAGR più elevato durante il periodo di previsione.
Approfondimenti basati sull'utente finale
In termini di utente finale, gli enzimi di biologia molecolare, i kit e il mercato dei reagenti è segmentato in aziende biotecnologiche e farmaceutiche, ospedali e centri diagnostici e istituti accademici e di ricerca. Il segmento delle aziende biotecnologiche e farmaceutiche ha detenuto la quota maggiore del mercato nel 2020 e si stima che lo stesso segmento registrerà il CAGR più elevato durante il periodo di previsione.
Gli attori del mercato degli enzimi, dei kit e dei reagenti per biologia molecolare stanno adottando le strategie di lancio e di espansione del prodotto per soddisfare le mutevoli richieste dei clienti in tutto il mondo, che consentono loro di mantenere il proprio marchio a livello globale.
Mercato degli enzimi, dei kit e dei reagenti per biologia molecolare: per prodotto
- Enzimi
- Polimerasi
- Ligasi
- Trascrittasi inverse
- Fosfatasi < li>Proteasi e proteinasi
- Endonucleasi di restrizione
- Altro
- Liofilizzabile e asciugabile all'aria
- NGS
- PCR
- PCR in tempo reale/ PCR quantitativa in tempo reale (qPCR)
- PCR con trascrittasi inversa (RT-PCR)
- PCR multiplex
- Altro
Mercato degli enzimi, dei kit e dei reagenti per la biologia molecolare - per applicazione
- Epigenetica
- Sequenziamento
- Biologia sintetica
- Reazione a catena della polimerasi
- Altro
Mercato degli enzimi, dei kit e dei reagenti per la biologia molecolare - per Utente finale
- Aziende biotecnologiche e farmaceutiche
- Ospedali e centri diagnostici
- Istituti accademici e di ricerca
Mercato degli enzimi, dei kit e dei reagenti per biologia molecolare: per area geografica
- Nord America
- Stati Uniti
- Canada
- Messico
< li>Europa - Francia
- Germania
- Italia
- Regno Unito
- Spagna
- Resto dell'Europa
- Asia Pacifico (APAC)
- Cina
- India
- Corea del Sud
- Giappone
- Australia
- Resto dell'APAC
- Medio Oriente e Asia Africa (MEA)
- Sudafrica
- Arabia Saudita
- EAU
- Resto del MEA
- America del Sud e America Centrale (SCAM)
- Brasile
- Argentina
- Resto dello SCAM
< /ul> - THERMO FISHER SCIENTIFIC INC
- Illumina, Inc.
- Qiagen
- Agilent Technologies , Inc.
- F. HOFFMANN-LA ROCHE LTD
- Merck KGAA
- Jena Bioscience GmbH
- Bioline Technologies
- Promega Corporation
- Rockland Immunochimici
Profili aziendali
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Biological enzymes play a prominent role in encouraging chemical reactions in biological systems. Molecular biology enzymes are recommended for the preparation of laboratory samples. These reagents are also utilized during PCR, DNA sequencing, and cell analysis amongst others.
The growth of the molecular biology enzymes, kits, and reagents market is attributed to a few key driving factors such as healthy funding for genomics, declining cost of sequencing procedures, and increasing prevalence of chronic diseases.
Based on product, molecular biology enzymes, kits, and reagents market is bifurcated into enzymes and kits & reagents. In 2020, kits & reagents held the largest segment, and moreover, the same segment is expected to grow at the highest CAGR during the forecast period.
The sequencing segment dominated the global molecular biology enzymes, kits, and reagents market and accounted for the largest revenue of US$ 3,815.02 Mn in 2020.
Global molecular biology enzymes, kits & reagents market is segmented by region into North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America. North America dominates the global molecular biology enzymes, kits & reagents market and is expected to hold its strong foothold in the coming years. The region is expected to witness consistent growth owing to factors such as rapid sequencing technologies, increasing preference for personalized medicine, increasing competition between the market player, high R&D spending to develop new sequencing products, and sophisticated infrastructure.
The Asia Pacific region is expected to account for the fastest growth in the molecular biology enzymes, kits & reagents market. In India and China, the market is expected to grow rapidly owing to factors such as the rise in the development and research for genomics and the rise in the programs for the genomics are expected to drive the molecular biology enzymes, kits & reagents market in the forecast period. In addition, the initiatives by the government of India for the startups in biotechnology sectors.
The molecular biology enzymes, kits, and reagents market majorly consists of the players such as THERMO FISHER SCIENTIFIC INC; Illumina, Inc.; Qiagen; Agilent Technologies, Inc.; F. HOFFMANN-LA ROCHE LTD; Merck KGAA; Jena Bioscience GmbH; Bioline Technologies; Promega Corporation; and Rockland Immunochemicals Inc amongst others.
The List of Companies - Molecular Biology Enzymes, Kits, and Reagents Market
- THERMO FISHER SCIENTIFIC INC
- Illumina, Inc.
- Qiagen
- Agilent Technologies, Inc.
- F. HOFFMANN-LA ROCHE LTD
- Merck KGAA
- Jena Bioscience GmbH
- Bioline Technologies
- Promega Corporation
- Rockland Immunochemicals Inc
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
Jun 2022
Bioprocessing Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Instruments, and Consumables and Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell and Gene Therapy, and Others), End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Jun 2022
Bioproduction Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product (Biologics and Biosimilars, Vaccines, Cell and Gene Therapies, Nucleic Acid Therapeutics, and Others), Application (Rheumatoid Arthritis, Hematological Disorders, Cancer, Diabetes, Cardiovascular Diseases, and Others), Equipment (Upstream Equipment, Downstream Equipment, Bioreactors, and Consumables and Accessories), End User (Biopharmaceutical Companies, Contract Manufacturing Organizations, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jun 2022
ELISA Diagnostic Test Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Adoption (Human and Veterinary), Test Type (Sandwich ELISA, Indirect ELISA, Competitive ELISA, and Multiple & Portable ELISA), Application (Autoimmune Diseases, Infectious Diseases, Cancer Diagnosis, Protein Quantification, and Others), End User (Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Veterinary Hospitals & Diagnostic Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Jun 2022
Swine Diagnostics Market
Size and Forecasts (2022 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product Type [Immunoassays Kits, PCR Kits, Hemagglutination Inhibition (HI), and Others], Sample Type (Blood, Oral Fluids, Nasal Swabs, Tissue Samples, and Others), Disease [African Swine Fever (ASF)/Classical Swine Fever (CSF), Respiratory Diseases, Porcine Circovirus, Porcine Epidemic Diarrhea, Swine Dysentery, and Others], End User (Veterinary Hospitals, Veterinary Clinics, and Other End Users), and Geography
Jun 2022
Microbial Identification Methods Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Method (Genotypic, Phenotypic, and Proteotypic), Type (Bacterial Identification System, Microbial Enumeration System, Bacterial Resistance Identification Systems, Microbiology Analyzer, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America)
Jun 2022
Biopharmaceuticals Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Monoclonal Antibodies, Recombinant Vaccines, Conventional Vaccines, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Recombinant Enzymes, Cell & Gene Therapies, Cytokines/Interferon/Interleukins, and Others) and Application (Oncology, Inflammatory & Infectious Disease, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders & Growth Failure, Cardiovascular Diseases, Neurological Diseases, and Others)
Jun 2022
GMP Cell Therapy Consumables Market
Forecast to 2028 - COVID-19 Impact and Global Analysis by Product (Kits, Reagents/Molecular Biology Reagents, Growth Factors/Cytokines and Interleukins, and Others), Cell Therapy (NK Cell Therapy, Stem Cell Therapy, T-Cell Therapy, and Others), Process (Cell Collection and Characterization/Sorting and Separation, Cell Culture and Expansion/Preparation, Cryopreservation, Cell Processing and Formulation, Cell Isolation and Activation, Cell Distribution/Handling, Process Monitoring and Control/Readministration/Quality Assurance, and Others), and End Use (Clinical, Commercial, and Research)